Skip to content

PARALLAX HEALTH SCIENCES, INC.: 10-Q/A filed 2011-09-06

What PARALLAX HEALTH SCIENCES, INC. reported in its quarterly report amendment filed 2011-09-06 (fiscal Q2 2011): 22 published measures, 76 facts as tagged in accession 0001078782-11-002562.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2011-09-06
Fiscal period
fiscal Q2 2011
Accession
0001078782-11-002562 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All PARALLAX HEALTH SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-3028,054USD
At 2010-12-3140,649USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-30-668,781USD
At 2010-12-31-569,049USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-3017,457USD
At 2010-12-3127,802USD
At 2010-06-300USD
At 2009-12-310USD
At 2005-07-050USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-75,345USD181
2005-07-06 to 2011-06-30-466,524USD2186
2010-01-01 to 2010-06-30-24,466USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2005-07-06 to 2011-06-30-13,500USD2186
2010-01-01 to 2010-06-300USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-04-01 to 2011-06-3049,385USD91
2011-01-01 to 2011-06-30192,246USD181
2005-07-06 to 2011-06-30212,643USD2186
2010-04-01 to 2010-06-300USD91
2010-01-01 to 2010-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-3065,000USD181
2005-07-06 to 2011-06-301,489,576USD2186
2010-01-01 to 2010-06-3024,466USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2005-07-06 to 2011-06-30-13,500USD2186
2010-01-01 to 2010-06-300USD181

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-04-01 to 2011-06-30153,958,513shares91
2011-01-01 to 2011-06-30151,580,473shares181
2010-04-01 to 2010-06-3074,657,431shares91
2010-01-01 to 2010-06-3071,788,752shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-3010,597USD
At 2010-12-3112,847USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-302,145USD91
2011-01-01 to 2011-06-30-1,894,809USD181
2005-07-06 to 2011-06-30-7,515,790USD2186
2010-04-01 to 2010-06-30-21,341USD91
2010-01-01 to 2010-06-30-44,655USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-3017,457USD
At 2010-12-3127,802USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-12,407USD91
2011-01-01 to 2011-06-30-24,590USD181
2005-07-06 to 2011-06-30-951,071USD2186
2010-04-01 to 2010-06-30-606,035USD91
2010-01-01 to 2010-06-30-729,733USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-30696,835USD
At 2010-12-31609,698USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-3041,904USD91
2011-01-01 to 2011-06-301,996,964USD181
2005-07-06 to 2011-06-307,602,296USD2186
2010-04-01 to 2010-06-3021,341USD91
2010-01-01 to 2010-06-3044,655USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-3044,049USD91
2011-01-01 to 2011-06-30102,155USD181
2005-07-06 to 2011-06-3086,506USD2186
2010-04-01 to 2010-06-300USD91
2010-01-01 to 2010-06-300USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-30151,063,898shares
At 2010-12-31144,563,898shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-06-3017,529,437USD
At 2010-12-3115,716,270USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-1,919,399USD181
2005-07-06 to 2011-06-30-11,757,187USD2186
2010-01-01 to 2010-06-30-969,388USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-308,232USD91
2011-01-01 to 2011-06-3054,644USD181
2005-07-06 to 2011-06-304,343,720USD2186
2010-04-01 to 2010-06-301,173USD91
2010-01-01 to 2010-06-301,848USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-10,262USD91
2011-01-01 to 2011-06-30-24,590USD181
2005-07-06 to 2011-06-30-4,241,397USD2186
2010-04-01 to 2010-06-30-801,035USD91
2010-01-01 to 2010-06-30-924,733USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2005-07-06 to 2011-06-3083,991USD2186
2010-01-01 to 2010-06-300USD181

Inspect the source

Entity
PARALLAX HEALTH SCIENCES, INC. / CIK 0001388410
Captured
SEC response SHA-256
94ef7b5cf30837ee48a9b3f8b759fe12b3da087f5b0a8ff4d38505bc8677ecf0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388410.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))